SecBot SecBot
SECBOTREPLAY Home › Report › MS

MS · Morgan Stanley's Q2 2026 13F filing reveals a portfolio with a total…

MORGAN STANLEY · 13F-HR filed Aug 13, 2026 at 14:51 ET

At the news

BULLISHIMPACT 6/10

13F-HR filed Aug 13, 2026 at 14:51 ET

Morgan Stanley's Q2 2026 13F filing reveals a portfolio with a total value of approximately $1.89 trillion, filed shortly after the company reported record quarterly results. The filing shows significant new positions in AbSci Corporation, Eos Energy Enterprises, and Harmony Biosciences, alongside substantial increases in existing positions like Rhythm Pharmaceuticals and Standard Lithium. The portfolio also reflects a rotation into energy and materials sectors, with notable increases in Canadian Natural Resources and Permian Resources, while reducing exposure to some financial and tech names. The filing is consistent with the firm's strong earnings report, which saw record net revenues of $21.3B and a $20B buyback authorization, suggesting a confident deployment of capital into growth and thematic areas.

  • Total portfolio value of approximately $1.89 trillion as of June 30, 2026.
  • New positions include AbSci Corporation ($11.6M), Eos Energy Enterprises ($7.4M), and Harmony Biosciences ($7.4M).
  • Significant increases in Rhythm Pharmaceuticals (853,492 shares), Standard Lithium (1.47M shares), and Canadian Natural Resources (10.67M shares).
  • Top holdings by value include NVIDIA ($23.0B), Amazon ($2.0B), Chevron ($3.2B), and Berkshire Hathaway ($5.8B).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access